Corin Group earns FDA clearance for robotic knee platform

Corin Group earned FDA 510(k) clearance for its Apollo robotic platform and software for total knee replacements, according to a Nov. 1 news release.

Advertisement

The system used Corin Group’s proprietary BalanceBot technology, which helps achieve personalize dynamic balance for patients. 

Corin Group is based in the United Kingdom. 

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Robotics

Advertisement

Comments are closed.